These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 36706773)

  • 21. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
    Kaushik M; Burdon MA
    J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls.
    Gaudioso CM; Mar S; Casper TC; Codden R; Nguyen A; Aaen G; Benson L; Chitnis T; Francisco C; Gorman MP; Goyal MS; Graves J; Greenberg BM; Hart J; Krupp L; Lotze T; Narula S; Pittock SJ; Rensel M; Rodriguez M; Rose J; Schreiner T; Tillema JM; Waldman A; Weinstock-Guttman B; Wheeler Y; Waubant E; Flanagan EP;
    Ann Neurol; 2023 Feb; 93(2):271-284. PubMed ID: 36088544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment].
    Wildemann B; Horstmann S; Korporal-Kuhnke M; Viehöver A; Jarius S
    Klin Monbl Augenheilkd; 2020 Nov; 237(11):1290-1305. PubMed ID: 33202462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
    Jarius S; Aktas O; Ayzenberg I; Bellmann-Strobl J; Berthele A; Giglhuber K; Häußler V; Havla J; Hellwig K; Hümmert MW; Kleiter I; Klotz L; Krumbholz M; Kümpfel T; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Tumani H; Wildemann B; Trebst C;
    J Neurol; 2023 Jul; 270(7):3341-3368. PubMed ID: 37022481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS.
    Xu Q; Yang X; Qiu Z; Li D; Wang H; Ye H; Jiao L; Zhang J; Di L; Lei P; Dong H; Liu Z
    Mult Scler Relat Disord; 2023 Sep; 77():104797. PubMed ID: 37402345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD).
    Mewes D; Kuchling J; Schindler P; Khalil AAA; Jarius S; Paul F; Chien C
    Klin Monbl Augenheilkd; 2022 Nov; 239(11):1315-1324. PubMed ID: 36410333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid eosinophils in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease.
    Kornbluh AB; Campano VM; Har C; Dwivedi P; Suslovic W; Sepeta L; Kahn I
    Mult Scler Relat Disord; 2024 May; 85():105526. PubMed ID: 38489945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges.
    Al-Ani A; Chen JJ; Costello F
    J Neurol; 2023 Aug; 270(8):4132-4150. PubMed ID: 37154894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
    Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B;
    J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
    Bruijstens AL; Lechner C; Flet-Berliac L; Deiva K; Neuteboom RF; Hemingway C; Wassmer E; ; Baumann M; Bartels F; Finke C; Adamsbaum C; Hacohen Y; Rostasy K
    Eur J Paediatr Neurol; 2020 Nov; 29():2-13. PubMed ID: 33162302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].
    Jarius S; Paul F; Aktas O; Asgari N; Dale RC; de Seze J; Franciotta D; Fujihara K; Jacob A; Kim HJ; Kleiter I; Kümpfel T; Levy M; Palace J; Ruprecht K; Saiz A; Trebst C; Weinshenker BG; Wildemann B
    Nervenarzt; 2018 Dec; 89(12):1388-1399. PubMed ID: 30264269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
    Gericke FC; Hanson JVM; Hackenberg A; Gerth-Kahlert C
    Eur J Paediatr Neurol; 2024 Jan; 48():113-120. PubMed ID: 38217965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
    van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
    Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
    Cortese R; Battaglini M; Prados F; Bianchi A; Haider L; Jacob A; Palace J; Messina S; Paul F; Wuerfel J; Marignier R; Durand-Dubief F; de Medeiros Rimkus C; Callegaro D; Sato DK; Filippi M; Rocca MA; Cacciaguerra L; Rovira A; Sastre-Garriga J; Arrambide G; Liu Y; Duan Y; Gasperini C; Tortorella C; Ruggieri S; Amato MP; Ulivelli M; Groppa S; Grothe M; Llufriu S; Sepulveda M; Lukas C; Bellenberg B; Schneider R; Sowa P; Celius EG; Proebstel AK; Yaldizli Ö; Müller J; Stankoff B; Bodini B; Carmisciano L; Sormani MP; Barkhof F; De Stefano N; Ciccarelli O;
    Brain; 2023 Jun; 146(6):2489-2501. PubMed ID: 36515653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Paediatric Patients with Optic Neuritis].
    Tegetmeyer H; Merkenschlager A
    Klin Monbl Augenheilkd; 2017 Oct; 234(10):1243-1249. PubMed ID: 29025172
    [No Abstract]   [Full Text] [Related]  

  • 39. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination.
    Ayroza Galvão Ribeiro Gomes AB; Kulsvehagen L; Lipps P; Cagol A; Cerdá-Fuertes N; Neziraj T; Flammer J; Lerner J; Lecourt AC; de Oliveira S Siebenborn N; Cortese R; Schaedelin S; Andreoli Schoeps V; de Moura Brasil Matos A; Trombini Mendes N; Dos Reis Pereira C; Ribeiro Monteiro ML; Dos Apóstolos-Pereira SL; Schindler P; Chien C; Schwake C; Schneider R; Pakeerathan T; Aktas O; Fischer U; Mehling M; Derfuss T; Kappos L; Ayzenberg I; Ringelstein M; Paul F; Callegaro D; Kuhle J; Papadopoulou A; Granziera C; Pröbstel AK
    JAMA Neurol; 2023 Sep; 80(9):989-995. PubMed ID: 37548987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.